L-Indanylglycine is a non-proteinogenic amino acid derivative characterized by an indane ring system fused to a glycine moiety, with the L-configuration at the chiral center. This structure imparts specific steric and electronic properties, making it a valuable chiral building block. Its primary application is in pharmaceutical research and development as a key intermediate for the synthesis of novel drug candidates. Notably, it serves as a crucial component in the preparation of potent and selective inhibitors for various enzymes and receptors. For instance, derivatives of L-indanylglycine have been investigated in the design of inhibitors targeting renin, an enzyme involved in blood pressure regulation, and other therapeutically relevant targets. As a chiral amino acid analog, it is utilized to introduce conformational constraints into peptide backbones, potentially enhancing metabolic stability and binding affinity. Its synthesis and application are of significant interest in medicinal chemistry for creating peptidomimetics and other bioactive molecules.